Xact Kapitalforvaltning’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$1.18M Sell
8,141
-1,138
-12% -$189K 0.03% 463
2019
Q4
$1.58M Buy
9,279
+351
+4% +$65.1K 0.03% 474
2019
Q3
$1.59M Buy
8,928
+342
+4% +$73.9K 0.03% 438
2019
Q2
$2.24M Buy
8,586
+925
+12% +$245K 0.05% 358
2019
Q1
$2.19M Buy
7,661
+749
+11% +$249K 0.05% 346
2018
Q4
$2.25M Sell
6,912
-813
-11% -$282K 0.06% 314
2018
Q3
$3.47M Sell
7,725
-578
-7% -$228K 0.07% 252
2018
Q2
$3.4M Buy
8,303
+2,859
+53% +$1.04M 0.07% 268
2018
Q1
$1.58M Buy
5,444
+1,800
+49% +$456K 0.04% 455
2017
Q4
$683K Buy
+3,644
New +$680K 0.02% 596

Other funds holding ABMD

Xact Kapitalforvaltning's ABMD Position: Q1 2020 in Review

Xact Kapitalforvaltning reduced its Abiomed Inc (ABMD) stake by 12% in Q1 2020, selling an estimated $189K and leaving 8,141 shares worth $1.18M. The position accounts for 0.03% of the portfolio, ranked #463.

Xact Kapitalforvaltning first reported a position in ABMD in Q4 2017 and has held it in 10 quarters since. The position peaked at $3.47M in Q3 2018. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • Xact Kapitalforvaltning held 8,141 shares of Abiomed Inc worth $1.18M as of Q1 2020.
  • Xact Kapitalforvaltning sold 1,138 Abiomed Inc shares in Q1 2020, an estimated $189K.
  • Abiomed Inc made up 0.03% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #463 holding.
  • Xact Kapitalforvaltning first reported a position in Abiomed Inc in Q4 2017 and has held it in 10 quarters since.
  • Xact Kapitalforvaltning's Abiomed Inc position peaked at $3.47M in Q3 2018.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.